Abipre Tablet 10/40 Milligrams
Amlodipine Besylate 13.888mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Taeguk Pharmaceutical Co., Ltd.
MFDS item code 201907079 · Approved 2019.10.04
This product's status changed to Expired on 2024.10.04. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension not controlled with monotherapy
This medication is used for the treatment of essential hypertension in cases where blood pressure is not sufficiently controlled by monotherapy with amlodipine or olmesartan medoxomil. It helps to lower blood pressure and reduce the risk of cardiovascular diseases. It contributes to reducing the likelihood of complications from hypertension and improving overall heart health. Therefore, it is a suitable treatment option for patients with difficult-to-control blood pressure.
Take 1 tablet once daily with water, with or without food. If possible, it is recommended that the dose be taken at the same time each day (e.g., in the morning). Before starting this drug, it is recommended that the dose be adjusted using the individual components (amlodipine or olmesartan medoxomil). However, if blood pressure is not adequately controlled with monotherapy using either individual component, switching directly to this drug may be considered. The maximum dose of this drug is 10/40 milligrams. The maximum blood pressure-lowering effect occurs within 2 weeks of administration; therefore, adjust the dose at intervals of 2 weeks or longer, taking the patient's blood pressure response into consideration. The recommended doses are as follows. - 5/20 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or olmesartan medoxomil 20 milligrams as monotherapy. - 10/20 milligrams: For patients whose blood pressure is not adequately controlled with olmesartan medoxomil 20 milligrams as monotherapy. - 5/40 milligrams: For patients whose blood pressure is not adequately controlled with 5/20 milligrams. - 10/40 milligrams: For patients whose blood pressure is not adequately controlled with 5/40 milligrams. ∘Patients with renal impairment: This drug has not been studied in patients with renal impairment. However, the maximum dose of olmesartan medoxomil for patients with mild to moderate renal impairment (creatine clearance 20-60mL/min) is 20 milligrams once daily. This drug is not recommended for patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or patients on dialysis. Monitoring of potassium and creatinine levels is recommended in patients with moderate renal impairment. ∘Patients with reduced effective intravascular volume: For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to start treatment at a low dose with close monitoring of their condition. ∘Patients with hepatic impairment: Use with caution in patients with mild to moderate hepatic impairment. The recommended initial dose of olmesartan medoxomil for patients with moderate hepatic impairment is 10 milligrams once daily, and the maximum dose is 20 milligrams once daily. Patients with hepatic impairment who are already receiving other antihypertensive drugs and/or diuretics should be closely monitored for blood pressure and renal function. This drug should not be administered to patients with severe hepatic impairment. (See Precautions for Use, 2. Patients in Whom the Drug Must Not Be Administered.) ∘Elderly patients: In general, start treatment at a low dose. When adjusting the dose, consider the patient's renal or cardiac function and comorbidities. In elderly patients, blood pressure should be monitored closely and more frequently.
∘Pediatric patients: The safety and efficacy of this drug have not been established in pediatric patients under 18 years of age.
This medication can cause serious harm to the fetus and newborn when taken during the second and third trimesters of pregnancy, so it must be discontinued immediately if pregnancy is confirmed. Patients who are allergic to the active ingredients or similar class drugs, pregnant women, breastfeeding women, patients with severe liver or aortic valve disease, patients with biliary obstruction, patients undergoing kidney dialysis, patients in shock, specific diabetic patients, and patients with severely impaired kidney function should not use this medication. It should be used with caution in patients with dehydration or low sodium levels, as hypotension may occur, and should be carefully administered to patients at risk of rapid blood pressure drop due to vasodilation, patients with coronary artery disease, patients with congestive heart failure, patients with weakened kidney function, and patients with impaired liver function. During use, side effects such as dizziness, headache, drowsiness, lowered blood pressure, nausea, vomiting, rash, and swelling may occur, so if symptoms are severe, consult a healthcare professional immediately. Although different from beta-blockers, this medication may interact with other blood pressure medications or specific drugs, so all medications being taken should be disclosed to the physician. During pregnancy, it may pose a risk to the fetus, so it is recommended to use safer alternative medications if planning to become pregnant or if already pregnant. If breastfeeding, as this medication can be transferred through breast milk and affect the baby, its use should be considered carefully. It is advisable not to use in children under 18 years of age, as safety and efficacy have not been established. Elderly patients may have reduced kidney and liver function, so it is recommended to start with a low dose and carefully monitor their condition. In case of overdose, severe hypotension and impaired heart function may occur, requiring immediate medical attention and continuous monitoring of blood pressure and heart status. This medication should be kept out of reach of children and stored in a cool place, avoiding direct sunlight and moisture.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is also best to store it at room temperature between 1°C and 30°C, avoiding extremely hot or cold places.
Reddish-brown round film-coated tablet
30 tablets (10 tablets/PTP×3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Amlodipine Besylate 13.888mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Taeguk Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg
Tablet · Prescription medication · Combination
Hanmi Daiichi Sankyo Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
Co., Ltd. Sainex
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.